%0 Journal Article
%T The Role of Adjuvant Therapy in Gastrointestinal Stromal Tumor after Operative Treatment
%A Ka-Ho Lok
%J Clinical Medicine Insights: Gastroenterology
%D 2012
%I 
%X The treatment for localized advance gastrointestinal stromal tumor (GIST) is far from ideal. Up to 50% of patient developed post-operative recurrence and died within 5 years. Recently, imatinib was found to significantly improve recurrence-free survival in post-operative patients. The role of adjuvant therapy in high risk GIST patients is discussed.
%U http://www.la-press.com/the-role-of-adjuvant-therapy-in-gastrointestinal-stromal-tumor-after-o-article-a1683